Presentation Title

Next Generation Sequencing: A Tool For Cancer Reseach and The Development of Precision Cancer Medicine

Presenter's Name(s)

Lauren M. CozzensFollow

Project Collaborators

Aaron Thorner Ph. D. (Intership Supervisor/Mentor)

Time

2:00 PM

Location

Chittenden Bank Room

Abstract

This event will describe my experience as a student intern at the Dana-Farber Cancer Institute Center For Cancer Genome Discovery (CCGD). The mission of CCGD is to develop new technologies for the analysis of cancer genomes while making these technologies available to translational and clinical investigators. Through studies conducted utilizing Next Generation Sequencing technology, researchers can discover genomic alterations that contribute to human cancer and evaluate the clinical significance of such alterations for experimental therapeutic trials, opening the doors for the development of precision cancer medicine. Through my time at CCGD I assisted with various sequencing projects that gave researchers around the world access to cutting edge genomic technology platforms and data analysis tools.

Primary Faculty Mentor Name

Aaron Thorner

Status

Undergraduate

Student College

College of Agriculture and Life Sciences

Program/Major

Molecular Genetics

Primary Research Category

Health Sciences

Secondary Research Category

Biological Sciences

This document is currently not available here.

Share

COinS
 

Next Generation Sequencing: A Tool For Cancer Reseach and The Development of Precision Cancer Medicine

This event will describe my experience as a student intern at the Dana-Farber Cancer Institute Center For Cancer Genome Discovery (CCGD). The mission of CCGD is to develop new technologies for the analysis of cancer genomes while making these technologies available to translational and clinical investigators. Through studies conducted utilizing Next Generation Sequencing technology, researchers can discover genomic alterations that contribute to human cancer and evaluate the clinical significance of such alterations for experimental therapeutic trials, opening the doors for the development of precision cancer medicine. Through my time at CCGD I assisted with various sequencing projects that gave researchers around the world access to cutting edge genomic technology platforms and data analysis tools.